ADC Therapeutics

ADCTNYSE Switzerland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$142.988 M

$1.12 +6.67%

Close of 21 Sept 2026

Revenue

$81.4M

#2576 by revenue

Earnings

-$142.6M

Loss-making

Shares outstanding

127,667,695

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#286ImmunicIMUX$147.8M
#287Korro BioKRRO$147.0M
#288ADC TherapeuticsADCT$143.0M
#289NRX PharmaceuticalsNRXP$142.4M
#290TuHURA BiosciencesHURA$138.9M

What if ADC Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$237,131.67

Per share 211,725× higher

Bitcoin $1.72T

$13,470.94

Per share 12,028× higher

Nvidia $5.48T

$42,922.82

Per share 38,324× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for ADC Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.